Relx Plc
—- Market cap
- —
- Debt
- +$11.78B
- Cash
- −$131.00M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: RELX stock price vs HIMS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HIMS's multiple
Needs HIMS P/E.
Implied fair value · at RELX's multiple
Needs RELX P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: RELX FY 2025 (ended Dec 31, 2025) · HIMS FY 2025 (ended Dec 31, 2025).
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
RELX PLC · implied price per share
Bear
$1.83
Base
$2.16
Bull
$2.48
HIMS & HERS HEALTH, INC. · implied price per share
Bear
-$3.14
Base
-$3.69
Bull
-$4.25
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
2.48x
Net debt / EBITDA
Leverage against operating earnings
5.60x
7.54x
Cash and equivalents
Liquid reserves on the balance sheet
$131.00M
$228.62M
Total debt
Interest-bearing obligations outstanding
$11.78B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
THOMSON REUTERS CORP /CAN/
RELX vs TRI
S&P Global Inc.
RELX vs SPGI
FACTSET RESEARCH SYSTEMS INC
RELX vs FDS
COSTAR GROUP, INC.
RELX vs CSGP
MOODYS CORP /DE/
RELX vs MCO
Teladoc Health, Inc.
RELX vs TDOC
GoodRx Holdings, Inc.
RELX vs GDRX
CLOVER HEALTH INVESTMENTS, CORP. /DE
RELX vs CLOV
Roivant Sciences Ltd.
RELX vs ROIV
$1.34B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.